Literature DB >> 33554248

A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases.

Changlu Qi1, Ping Wang1, Tongze Fu1, Minke Lu1, Yiting Cai1, Xu Chen1, Liang Cheng1.   

Abstract

Gut microbes have attracted much more attentions in the recent decade since their essential roles in the development of metabolic diseases, cancer and neurological diseases. Considerable evidence indicates that the metabolism of gut microbes exert influences on intestinal homeostasis and human diseases. Here, we first reviewed two mainstream sequencing technologies involving 16s rRNA sequencing and metagenomic sequencing for gut microbes, and data analysis methods assessing alpha and beta diversity. Next, we introduced some observational studies reflecting that many factors, such as lifestyle and intake of diets, drugs, contribute to gut microbes' quantity and diversity. Then, metabolites produced by gut microbes were presented to understand that gut microbes exert on host homeostasis in the intestinal epithelium and immune system. Finally, we focused on the molecular mechanism of gut microbes on the occurrence and development of several common diseases. In-depth knowledge of the relationship among interventions, gut microbes and diseases might provide new insights in to disease prevention and treatment.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  gut microbes; immune system; intestinal epithelium; metabolic disease; metabolite

Year:  2021        PMID: 33554248     DOI: 10.1093/bfgp/elaa029

Source DB:  PubMed          Journal:  Brief Funct Genomics        ISSN: 2041-2649            Impact factor:   4.241


  8 in total

1.  Metabolomics and Microbiomics: New Potential Strategies in Chronic Pain Syndrome.

Authors:  Cristina Piras; Bruno Maria Pintus; Antonio Noto; Maurizio Evangelista; Vassilios Fanos; Mario Musu; Michele Mussap; Luigi Atzori; Salvatore Sardo; Gabriele Finco
Journal:  J Pain Res       Date:  2022-03-11       Impact factor: 3.133

Review 2.  Mechanisms Underlying the Interaction Between Chronic Neurological Disorders and Microbial Metabolites via Tea Polyphenols Therapeutics.

Authors:  Mengyu Hong; Lu Cheng; Yanan Liu; Zufang Wu; Peng Zhang; Xin Zhang
Journal:  Front Microbiol       Date:  2022-03-25       Impact factor: 5.640

3.  Effect of Different Dietary Regimes on the Gut Microbiota and Fecal Metabolites of Père David's Deer.

Authors:  Junai Zhen; Yijun Ren; Huidan Zhang; Xueli Yuan; Libo Wang; Hua Shen; Ping Liu; Yuqing Chen
Journal:  Animals (Basel)       Date:  2022-02-25       Impact factor: 2.752

4.  Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure.

Authors:  Weiju Sun; Debing Du; Tongze Fu; Ying Han; Peng Li; Hong Ju
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

5.  Identification of Causal Genes of COVID-19 Using the SMR Method.

Authors:  Yan Zong; Xiaofei Li
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

6.  Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction.

Authors:  Ying Han; Zhaowei Gong; Guizhi Sun; Jing Xu; Changlu Qi; Weiju Sun; Huijie Jiang; Peigang Cao; Hong Ju
Journal:  Front Microbiol       Date:  2021-07-05       Impact factor: 5.640

7.  Prioritizing Disease-Related Microbes Based on the Topological Properties of a Comprehensive Network.

Authors:  Haixiu Yang; Fan Tong; Changlu Qi; Ping Wang; Jiangyu Li; Liang Cheng
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

8.  gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites.

Authors:  Liang Cheng; Changlu Qi; Haixiu Yang; Minke Lu; Yiting Cai; Tongze Fu; Jialiang Ren; Qu Jin; Xue Zhang
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.